Global Siltuximab Market Growth 2025-2031

December 2025 | 82 pages | ID: G54154DBB23EN
LP Information

Abstracts

The global Siltuximab market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Siltuximab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Siltuximab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Siltuximab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Siltuximab players cover Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Siltuximab Industry Forecast” looks at past sales and reviews total world Siltuximab sales in 2024, providing a comprehensive analysis by region and market sector of projected Siltuximab sales for 2025 through 2031. With Siltuximab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Siltuximab industry.

This Insight Report provides a comprehensive analysis of the global Siltuximab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Siltuximab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Siltuximab market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Siltuximab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Siltuximab.

This report presents a comprehensive overview, market shares, and growth opportunities of Siltuximab market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 100mg Injection
• 400mg Injection

Segmentation by Application:

• Hospital
• Clinic
• Drug Center
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Johnson & Johnson

Key Questions Addressed in this Report

What is the 10-year outlook for the global Siltuximab market?

What factors are driving Siltuximab market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Siltuximab market opportunities vary by end market size?

How does Siltuximab break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Siltuximab Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Siltuximab by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Siltuximab by Country/Region, 2020, 2024 & 2031
2.2 Siltuximab Segment by Type
  2.2.1 100mg Injection
  2.2.2 400mg Injection
2.3 Siltuximab Sales by Type
  2.3.1 Global Siltuximab Sales Market Share by Type (2020-2025)
  2.3.2 Global Siltuximab Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Siltuximab Sale Price by Type (2020-2025)
2.4 Siltuximab Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Drug Center
  2.4.4 Others
2.5 Siltuximab Sales by Application
  2.5.1 Global Siltuximab Sale Market Share by Application (2020-2025)
  2.5.2 Global Siltuximab Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Siltuximab Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Siltuximab Breakdown Data by Company
  3.1.1 Global Siltuximab Annual Sales by Company (2020-2025)
  3.1.2 Global Siltuximab Sales Market Share by Company (2020-2025)
3.2 Global Siltuximab Annual Revenue by Company (2020-2025)
  3.2.1 Global Siltuximab Revenue by Company (2020-2025)
  3.2.2 Global Siltuximab Revenue Market Share by Company (2020-2025)
3.3 Global Siltuximab Sale Price by Company
3.4 Key Manufacturers Siltuximab Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Siltuximab Product Location Distribution
  3.4.2 Players Siltuximab Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR SILTUXIMAB BY GEOGRAPHIC REGION

4.1 World Historic Siltuximab Market Size by Geographic Region (2020-2025)
  4.1.1 Global Siltuximab Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Siltuximab Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Siltuximab Market Size by Country/Region (2020-2025)
  4.2.1 Global Siltuximab Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Siltuximab Annual Revenue by Country/Region (2020-2025)
4.3 Americas Siltuximab Sales Growth
4.4 APAC Siltuximab Sales Growth
4.5 Europe Siltuximab Sales Growth
4.6 Middle East & Africa Siltuximab Sales Growth

5 AMERICAS

5.1 Americas Siltuximab Sales by Country
  5.1.1 Americas Siltuximab Sales by Country (2020-2025)
  5.1.2 Americas Siltuximab Revenue by Country (2020-2025)
5.2 Americas Siltuximab Sales by Type (2020-2025)
5.3 Americas Siltuximab Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Siltuximab Sales by Region
  6.1.1 APAC Siltuximab Sales by Region (2020-2025)
  6.1.2 APAC Siltuximab Revenue by Region (2020-2025)
6.2 APAC Siltuximab Sales by Type (2020-2025)
6.3 APAC Siltuximab Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Siltuximab by Country
  7.1.1 Europe Siltuximab Sales by Country (2020-2025)
  7.1.2 Europe Siltuximab Revenue by Country (2020-2025)
7.2 Europe Siltuximab Sales by Type (2020-2025)
7.3 Europe Siltuximab Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Siltuximab by Country
  8.1.1 Middle East & Africa Siltuximab Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Siltuximab Revenue by Country (2020-2025)
8.2 Middle East & Africa Siltuximab Sales by Type (2020-2025)
8.3 Middle East & Africa Siltuximab Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Siltuximab
10.3 Manufacturing Process Analysis of Siltuximab
10.4 Industry Chain Structure of Siltuximab

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Siltuximab Distributors
11.3 Siltuximab Customer

12 WORLD FORECAST REVIEW FOR SILTUXIMAB BY GEOGRAPHIC REGION

12.1 Global Siltuximab Market Size Forecast by Region
  12.1.1 Global Siltuximab Forecast by Region (2026-2031)
  12.1.2 Global Siltuximab Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Siltuximab Forecast by Type (2026-2031)
12.7 Global Siltuximab Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Johnson & Johnson
  13.1.1 Johnson & Johnson Company Information
  13.1.2 Johnson & Johnson Siltuximab Product Portfolios and Specifications
  13.1.3 Johnson & Johnson Siltuximab Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Johnson & Johnson Main Business Overview
  13.1.5 Johnson & Johnson Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Siltuximab Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Siltuximab Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 100mg Injection
Table 4. Major Players of 400mg Injection
Table 5. Global Siltuximab Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Siltuximab Sales Market Share by Type (2020-2025)
Table 7. Global Siltuximab Revenue by Type (2020-2025) & ($ million)
Table 8. Global Siltuximab Revenue Market Share by Type (2020-2025)
Table 9. Global Siltuximab Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Siltuximab Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Siltuximab Sale Market Share by Application (2020-2025)
Table 12. Global Siltuximab Revenue by Application (2020-2025) & ($ million)
Table 13. Global Siltuximab Revenue Market Share by Application (2020-2025)
Table 14. Global Siltuximab Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Siltuximab Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Siltuximab Sales Market Share by Company (2020-2025)
Table 17. Global Siltuximab Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Siltuximab Revenue Market Share by Company (2020-2025)
Table 19. Global Siltuximab Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Siltuximab Producing Area Distribution and Sales Area
Table 21. Players Siltuximab Products Offered
Table 22. Siltuximab Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Siltuximab Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Siltuximab Sales Market Share Geographic Region (2020-2025)
Table 27. Global Siltuximab Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Siltuximab Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Siltuximab Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Siltuximab Sales Market Share by Country/Region (2020-2025)
Table 31. Global Siltuximab Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Siltuximab Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Siltuximab Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Siltuximab Sales Market Share by Country (2020-2025)
Table 35. Americas Siltuximab Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Siltuximab Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Siltuximab Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Siltuximab Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Siltuximab Sales Market Share by Region (2020-2025)
Table 40. APAC Siltuximab Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Siltuximab Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Siltuximab Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Siltuximab Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Siltuximab Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Siltuximab Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Siltuximab Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Siltuximab Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Siltuximab Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Siltuximab Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Siltuximab Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Siltuximab
Table 52. Key Market Challenges & Risks of Siltuximab
Table 53. Key Industry Trends of Siltuximab
Table 54. Siltuximab Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Siltuximab Distributors List
Table 57. Siltuximab Customer List
Table 58. Global Siltuximab Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Siltuximab Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Siltuximab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Siltuximab Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Siltuximab Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Siltuximab Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Siltuximab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Siltuximab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Siltuximab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Siltuximab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Siltuximab Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Siltuximab Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Siltuximab Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Siltuximab Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Johnson & Johnson Basic Information, Siltuximab Manufacturing Base, Sales Area and Its Competitors
Table 73. Johnson & Johnson Siltuximab Product Portfolios and Specifications
Table 74. Johnson & Johnson Siltuximab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Johnson & Johnson Main Business
Table 76. Johnson & Johnson Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Siltuximab
Figure 2. Siltuximab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Siltuximab Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Siltuximab Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Siltuximab Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Siltuximab Sales Market Share by Country/Region (2024)
Figure 10. Siltuximab Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 100mg Injection
Figure 12. Product Picture of 400mg Injection
Figure 13. Global Siltuximab Sales Market Share by Type in 2025
Figure 14. Global Siltuximab Revenue Market Share by Type (2020-2025)
Figure 15. Siltuximab Consumed in Hospital
Figure 16. Global Siltuximab Market: Hospital (2020-2025) & (K Pcs)
Figure 17. Siltuximab Consumed in Clinic
Figure 18. Global Siltuximab Market: Clinic (2020-2025) & (K Pcs)
Figure 19. Siltuximab Consumed in Drug Center
Figure 20. Global Siltuximab Market: Drug Center (2020-2025) & (K Pcs)
Figure 21. Siltuximab Consumed in Others
Figure 22. Global Siltuximab Market: Others (2020-2025) & (K Pcs)
Figure 23. Global Siltuximab Sale Market Share by Application (2024)
Figure 24. Global Siltuximab Revenue Market Share by Application in 2025
Figure 25. Siltuximab Sales by Company in 2025 (K Pcs)
Figure 26. Global Siltuximab Sales Market Share by Company in 2025
Figure 27. Siltuximab Revenue by Company in 2025 ($ millions)
Figure 28. Global Siltuximab Revenue Market Share by Company in 2025
Figure 29. Global Siltuximab Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Siltuximab Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Siltuximab Sales 2020-2025 (K Pcs)
Figure 32. Americas Siltuximab Revenue 2020-2025 ($ millions)
Figure 33. APAC Siltuximab Sales 2020-2025 (K Pcs)
Figure 34. APAC Siltuximab Revenue 2020-2025 ($ millions)
Figure 35. Europe Siltuximab Sales 2020-2025 (K Pcs)
Figure 36. Europe Siltuximab Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Siltuximab Sales 2020-2025 (K Pcs)
Figure 38. Middle East & Africa Siltuximab Revenue 2020-2025 ($ millions)
Figure 39. Americas Siltuximab Sales Market Share by Country in 2025
Figure 40. Americas Siltuximab Revenue Market Share by Country (2020-2025)
Figure 41. Americas Siltuximab Sales Market Share by Type (2020-2025)
Figure 42. Americas Siltuximab Sales Market Share by Application (2020-2025)
Figure 43. United States Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Siltuximab Sales Market Share by Region in 2025
Figure 48. APAC Siltuximab Revenue Market Share by Region (2020-2025)
Figure 49. APAC Siltuximab Sales Market Share by Type (2020-2025)
Figure 50. APAC Siltuximab Sales Market Share by Application (2020-2025)
Figure 51. China Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 55. India Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Siltuximab Sales Market Share by Country in 2025
Figure 59. Europe Siltuximab Revenue Market Share by Country (2020-2025)
Figure 60. Europe Siltuximab Sales Market Share by Type (2020-2025)
Figure 61. Europe Siltuximab Sales Market Share by Application (2020-2025)
Figure 62. Germany Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 63. France Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Siltuximab Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Siltuximab Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Siltuximab Sales Market Share by Application (2020-2025)
Figure 70. Egypt Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Siltuximab Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Siltuximab in 2025
Figure 76. Manufacturing Process Analysis of Siltuximab
Figure 77. Industry Chain Structure of Siltuximab
Figure 78. Channels of Distribution
Figure 79. Global Siltuximab Sales Market Forecast by Region (2026-2031)
Figure 80. Global Siltuximab Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Siltuximab Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Siltuximab Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Siltuximab Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Siltuximab Revenue Market Share Forecast by Application (2026-2031)